奎尔素通过FAM198B/MAPK路径调节抑制胃癌的进展
Hongyang Deng1, Qi Xiao1, Xiaodong Xu1
1Department of General Surgery, Hepatic-Biliary-Pancreatic Institute, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
Pharmacogenomics and personalized medicine
|May 20, 2025
概括
具有序列相似性的家族198成员B (FAM198B) 驱动胃癌 (GC) 的进展. 奎尔赛丁抑制FAM198B和MAPK通路,减少GC细胞生长和转移,提供一种潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 具有序列相似性的家族198成员B (FAM198B) 与胃癌 (GC) 的进展有关.
- 在GC中FAM198B的确切作用和分子机制在很大程度上仍未被阐明.
- 这项研究研究了FAM198B,氨酸和GC中的MAPK通路之间的联系.
研究的目的:
- 阐明FAM198B在胃癌中的作用和分子机制.
- 通过向FAM198B和MAPK通路,研究瑞对GC的潜在治疗效果.
主要方法:
- 在公共数据集和临床GC组织中的FAM198B表达式分析.
- 使用卡普兰-梅尔绘图器和考克斯回归的预后分析.
- 通过GSEA,联合表达分析和RNA测序来探索FAM198B的功能和途径.
- 试验室试验评估FAM198B的淘汰效应和奎尔丁向.
主要成果:
- 在GC组织中,FAM198B的表达很高,并且与预后不佳和免疫细胞透率增加有关.
- FAM198B的敲除抑制了GC细胞的增殖,迁移,入侵和上皮-介质酶过渡 (EMT).
- 在GC细胞中,FAM198B敲除和氨酸治疗减少了MAPK通路的酸化 (p-Erk1/2,p-p38).
结论:
- 奎瑞通过抑制FAM198B/MAPK信号通路来抑制GC细胞的增殖,迁移,入侵和EMT.
- 向FAM198B和利用奎尔丁为GC治疗提供了一个有前途的治疗途径.
- 需要进行进一步的临床前和临床研究,以验证奎尔丁和FAM198B向治疗在GC中的疗效和安全性.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:26NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
02:59Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
01:20The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K